CoChat

Cutting Edge: Priming of CTL by Transcutaneous Peptide Immunization with Imiquimod

Rechtsteiner, Gerd, Warger, Tobias, Osterloh, Philipp, Schild, Hansjörg, Radsak, Markus P · 2005 · The Journal of Immunology
Cited by 154

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

CTL are important in combating cancer and viruses. Therefore, triggering the complete potential of CTL effector functions by new vaccination strategies will not only improve prophylaxis of tumor or virus-related diseases, but also open opportunities for effective therapeutic immunizations. Using transcutaneous immunization, we show that epicutaneous (e.c.)4 application of an ointment containing a CTL epitope and the TLR7 ligand imiquimod is highly effective in activating T cells in mice using TCR-transgenic CTL or in wild-type mice. Transcutaneous immunization-activated CTL mount a full-blown immune response against the target epitope characterized by proliferation, cytolytic activity, and the production of IFN-γ that is completely restricted to the epitope used for vaccination. Our results obtained by simple e.c. application of an ointment, without further skin irritating procedures, provide the basis for the development of new, easy to use vaccines against cancer or virus-associated diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4049/jimmunol.174.5.2476

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 154

Metadata

Authors
Rechtsteiner, G., Warger, T., Osterloh, P., Schild, H., & Radsak, M. P.
Venue
The Journal of Immunology
Published
2005-03-01
Volume
174
Issue
5
Pages
2476-2480
ISSN
  • 0022-1767 (ISSN-L)
  • 1550-6606
OpenAlex
W2130657029
Cited by
154
References
2
FWCI
5.69
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cutting Edge: Priming of CTL by Transcutaneous Peptide Immunization with Imiquimod. https://app.cochat.ai/papers/10.4049/jimmunol.174.5.2476
The paper
Rechtsteiner, G., Warger, T., Osterloh, P., Schild, H., & Radsak, M. P. (2005). Cutting Edge: Priming of CTL by Transcutaneous Peptide Immunization with Imiquimod. The Journal of Immunology. https://doi.org/10.4049/jimmunol.174.5.2476

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.